Commensurate with our findings, IFN-γ levels are increased in the serum of COVID-19 patients, and also in healthy donor PBMCs infected ex-vivo with SARS-CoV-2 (6, 32, 38, 49). The gene discussed is IFNG; the disease is COVID-19.